Structural elucidation of two major metabolites of crisnatol in the rat by NMR and mass spectrometry
✍ Scribed by John P. Shockcor; Dipak K. Patel; Robert L. Johnson; Lester C. E. Taylor; Pisal Chandrasurin
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 556 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0749-1581
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
NMR and mass spectral data are presented in support of the structures of two metabolites of crisnatol, 2‐[(6‐chrysenylmethyl)amino]‐2‐methylpropane‐1,3‐diol, a novel DNA intercalator currently undergoing Phase II clinical trials as an anticancer agent. Elucidation of the structures of the major rat urinary metabolite as trans‐1,2‐dihydro‐1,2‐dihydroxycrisnatol, and the major rat fecal metabolite as 1‐hydroxycrisnatol, using 2D NMR techniques are described.
📜 SIMILAR VOLUMES
## Abstract The cyclic depsipeptide aplidine is a new anti‐cancer drug of marine origin. Four metabolites of this compound were found after incubation with pooled human microsomes using gradient high‐performance liquid chromatography with ultraviolet detection. After chromatographic isolation, the